Join us for this Vertex-sponsored symposium in which we are bringing together eminent experts in diabetes research and management to explore innovative approaches that have the potential to redefine type 1 diabetes (T1D) care, with a particular focus on islet cell therapy. Attendees will gain insights into the clinical progression of islet cell therapy to date and investigational strategies for scalable sources of islet cells with a review of clinical trials using this approach, including the latest clinical data for zimislecel*. We hope you can join us in Hall 114 on 11 March from 14:40 to 16:10 CET, for what promises to be an insightful and collaborative event, creating a unique opportunity to learn from international experts to elevate care for patients living with T1D.

*Zimislecel is an investigational product that has not been approved by any health authority.

Veeva ID: AC-63-2600028; Date of preparation: February 2026

Date: Wednesday, 11 March
Time: 14:40 – 16:10 CET
Venue: Hall 114

We look forward to seeing you there.